Researchers increased or suppressed thymosin beta4 expression in mouse fibrosarcoma cells and tested tumor behavior in mice.
What the researchers measured
Tumor formation, lung metastases, cell movement and shape, and actin organization were examined.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
Higher expression promoted aggressive behavior in this tumor model. The study concerns altered gene expression, not a peptide safety trial, but shows why repair-related mechanisms should not be assumed uniformly beneficial.
What this does not establish
A tumor-cell gene-expression experiment does not quantify cancer risk from administering TB-500, but demonstrates context-dependent biology rather than uniformly beneficial effects.
This collection includes related thymosin beta4 research. Parent or engineered peptide findings do not establish that a TB-500 fragment or a product sold under that name has the same effects.
Publication & source
Why this paper is included
The title focuses on thymosin beta4 or TB-500; parent-peptide findings do not establish TB-500 fragment effects.
Publication indexing
Journal Article · Research Support, Non-U.S. Gov't